The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes.

Factor IX is also called Christmas factor or antihaemophilia B factor and is one of the essential components in blood coagulation.

Your body may develop antibodies to Koate-DVI, making it less effective.

ADYNOVATE is a human antihemophilic factor indicated in children and adults with hemophilia A (congenital factor VIII deficiency) for:

Human antihemophilic factor is not for use in people with von Willebrand disease.

An example of such a protein is antihemophilic factor (FVIII).

ELOCTATE is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for:

ADYNOVATE is a human antihemophilic factor indicated in children and adults with hemophilia A (congenital factor VIII deficiency) for:

ADVATE is a recombinant antihemophilic factor indicated for use in children and adults with hemophilia A (congenital factor VIII deficiency) for:

Composition and methods are described for low immunogenic protein formulations.

What should I discuss with my health care provider before using human antihemophilic factor?

ELOCTATE is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for:

ADVATE is a recombinant antihemophilic factor indicated for use in children and adults with hemophilia A (congenital factor VIII deficiency) for:

Disclosed are improved recombinant adeno-associated viral (rAAV) vector compositions useful in the delivery of antihemophilic factor polypeptides to selected mammalian host cells.